快而精医药(QGEN)

48.97 0.07 0.1431%

今开:48.97昨收:48.9
最高:49.3 最低:48.895
涨停价:0.0跌停价:0.0
总市值:1.1150469E10

快而精医药的热门评论

美股滚雪球2021-11-04 11:25

有报道称$快而精医药(QGEN)$ 吸引了法国诊断公司bioMérieux的收购兴趣。
去年,$赛默飞世尔科技(TMO)$ 出价104亿欧元收购QGEN,但最终交易破裂,一周后Qigen董事长辞职,这次董事长还辞职吗?
$东方生物(SH688298)$查看全文

美股滚雪球2021-11-17 12:09

$赛默飞世尔科技(TMO)$ 据说又想并购$快而精医药(QGEN)$ 了,念念不忘,必有回响。$义翘神州(SZ301047)$查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

7X24快讯2021-07-12 23:14

市场消息:快而精医药(QGEN.N)将回购高达1亿美元股票。查看全文

JZee2021-06-21 09:41

$泛生子(GTH)$ 主页上有$快而精医药(QGEN)$ 合作字样。泛生子目前的检测服务和未来的肝癌早筛需给qiagen分成么?//@userfield:回复@张小丰:我倒是觉得这个行业现在不需要一口吃个胖子吧,应该是渐进式进步,先比临床日常用的检测方法有更好的灵敏度和特异性,然后采样方便,这样就有一定优势,可以...查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

快而精医药(QGEN)2021-05-05 18:42

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000031 Act: 34 Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

快而精医药(QGEN)2020-07-13 21:30

【异动】$快而精医药(QGEN)$ 21:30股价创60日新高,现价45.74美元,涨幅0.95%查看全文

快而精医药(QGEN)2020-07-10 21:30

【异动】$快而精医药(QGEN)$ 21:30股价创60日新高,现价44.78美元,涨幅0.52%查看全文

快而精医药(QGEN)2020-07-10 07:46

【异动】$快而精医药(QGEN)$ 盘后07:46跌幅达-4.60%,现价42.50美元查看全文

快而精医药(QGEN)2020-07-10 02:45

【异动】$快而精医药(QGEN)$ 02:45股价创60日新高,现价44.42美元,涨幅1.95%查看全文

快而精医药(QGEN)2020-07-10 01:40

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000030 Act: 34 Size: 60 KB 网页链接查看全文

快而精医药(QGEN)2020-07-07 04:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-081188 Act: 34 Size: 108 KB 网页链接查看全文

快而精医药(QGEN)2020-07-02 07:50

【异动】$快而精医药(QGEN)$ 盘后07:50涨幅达4.66%,现价44.70美元查看全文

快而精医药(QGEN)2020-07-01 21:05

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-079432 Act: 34 Size: 106 KB 网页链接查看全文

快而精医药(QGEN)2020-06-23 04:15

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-075629 Act: 34 Size: 103 KB 网页链接查看全文

快而精医药(QGEN)2020-06-16 05:20

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-073443 Act: 34 Size: 111 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30